Endocannabinoid signalling in the blood of patients with schizophrenia
AUTOR(ES)
De Marchi, Nicola
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=194767Documentos Relacionados
- Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey
- Volatile organic compounds in the breath of patients with schizophrenia.
- Antibodies to Thymocytes in Sera of Patients with Schizophrenia
- Rehabilitation of Patients with Schizophrenia and with Depressions
- Increased pentane and carbon disulfide in the breath of patients with schizophrenia.